844 related articles for article (PubMed ID: 12552406)
21. Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
Möhrle M; Schippert W; Rassner G; Garbe C; Breuninger H
Dermatology; 2004; 209(1):5-13. PubMed ID: 15237261
[TBL] [Abstract][Full Text] [Related]
22. [Management of lymph nodes in head and neck melanoma: a retrospective study of 25 cases].
Ricard AS; Majoufre-Lefebvre C; Delaunay M; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):505-8. PubMed ID: 17900640
[TBL] [Abstract][Full Text] [Related]
23. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
24. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
25. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
26. Desmoplastic and neurotropic melanoma.
Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
[TBL] [Abstract][Full Text] [Related]
27. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
[TBL] [Abstract][Full Text] [Related]
28. Prognostic variables for patients with stage III malignant melanoma.
Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC
Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339
[TBL] [Abstract][Full Text] [Related]
29. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP; Essner R; Turner RR; Ye X; Morton DL
Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous malignant melanoma of the head and neck.
Fisher SR
Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
[TBL] [Abstract][Full Text] [Related]
31. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
[TBL] [Abstract][Full Text] [Related]
32. Sentinel node dissection delays recurrence and prolongs melanoma-related survival: an analysis of 673 patients from a single center with long-term follow-up.
Satzger I; Meier A; Hoy L; Völker B; Kapp A; Hauschild A; Gutzmer R
Ann Surg Oncol; 2011 Feb; 18(2):514-20. PubMed ID: 20839060
[TBL] [Abstract][Full Text] [Related]
33. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
34. The management of cervical lymph nodes in patients with cutaneous melanoma.
Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
[TBL] [Abstract][Full Text] [Related]
35. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma.
van Egmond DB; Welvaart K; Hermans J; Ruiter DJ
Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926
[TBL] [Abstract][Full Text] [Related]
36. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
[TBL] [Abstract][Full Text] [Related]
37. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
38. [Relation between the prognosis of skin melanomas and the timing of appearance of regional metastases].
Vagner RI; Anisimov VV
Vopr Onkol; 1986; 32(10):21-5. PubMed ID: 3776125
[TBL] [Abstract][Full Text] [Related]
39. [Risk factors for lymph node metastasis in malignant melanoma].
Mussack T; Waldner H; Kharraz-Tavakol A
Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332
[TBL] [Abstract][Full Text] [Related]
40. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
